Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase IIa, Double-blind, Randomised, Placebo-Controlled Dose Escalation Study to Evalulate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450, a Caspase Inhibitor, in Subjects with Chronic Hepatitis C https://kusajili.fr:443/Trial/HGdvwgTphUqPtWDb0UisrQ%24a-phase-iia-double-blind-randomised-placebo-controlled-dose-escalation-study-to-evalulate-the-safety-tolerability-pharmacokinet
I have read and accept the terms of use of the site and the Privacy Policy
Send your message